Retraction: Parthenolide Augments the Chemosensitivity of Non-small-Cell Lung Cancer to Cisplatin via the PI3K/AKT Signaling Pathway

, Frontiers Editorial Office

doi:10.3389/fcell.2021.696217

RETRACTION article

Front. Cell Dev. Biol. , 05 May 2021

Sec. Cell Death and Survival

Volume 9 - 2021 | https://doi.org/10.3389/fcell.2021.696217

This article is part of the Research Topic Dynamical Networks of Life/Death Decisions in a Cell: From DNA Repair to Cell Death View all 19 articles

Retraction: Parthenolide Augments the Chemosensitivity of Non-small-Cell Lung Cancer to Cisplatin via the PI3K/AKT Signaling Pathway

This article is a retraction of:

RETRACTED: Parthenolide Augments the Chemosensitivity of Non-small-Cell Lung Cancer to Cisplatin via the PI3K/AKT Signaling Pathway
1. Read original article

$\nFrontiers Editorial Office$ Frontiers Editorial Office^*

A Retraction of the Original Research Article
Parthenolide Augments the Chemosensitivity of Non-small-Cell Lung Cancer to Cisplatin via the PI3K/AKT Signaling Pathway

by Wu, L.-M., Liao, X.-Z., Zhang, Y., He, Z.-R., Nie, S.-Q., Ke, B., et al. (2021). Front. Cell Dev. Biol. 8:610097. doi: 10.3389/fcell.2020.610097

Following publication, concerns were raised regarding image manipulation. The authors failed to provide a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers' guidelines.

This retraction was approved by the Chief Editors of Frontiers in Cellular and Development and the Editor-in-Chief of Frontiers. The authors [did] agree to this retraction.

Citation: Frontiers Editorial Office (2021) Retraction: Parthenolide Augments the Chemosensitivity of Non-small-Cell Lung Cancer to Cisplatin via the PI3K/AKT Signaling Pathway. Front. Cell Dev. Biol. 9:696217. doi: 10.3389/fcell.2021.696217

Received: 16 April 2021; Accepted: 16 April 2021;
Published: 05 May 2021.

Approved by:

Craig Michael Walsh, University of California, Irvine, United States

Copyright © 2021 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Editorial Office, ZWRpdG9yaWFsLm9mZmljZUBmcm9udGllcnNpbi5vcmc=

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Retraction: Parthenolide Augments the Chemosensitivity of Non-small-Cell Lung Cancer to Cisplatin via the PI3K/AKT Signaling Pathway

95% of researchers rate our articles as excellent or good

95% of researchers rate our articles as excellent or good